Q3 2025 Revenue of $21.8 million, an increase of 20% over Q3 2024;Q3 2025 gross profit margin of 81%, a 400-basis point improvement from Q3 ...
BD (Becton, Dickinson and Company) a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance and Conformité Européenne (CE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback